Skip to main
AMN
AMN logo

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 57%
Hold 14%
Sell 14%
Strong Sell 0%

Bulls say

AMN Healthcare Services Inc reported 2Q25 revenue of $658.2 million, which, despite being down 11% year-over-year, exceeded both internal estimates and consensus forecasts. The company's gross margin increased significantly to 29.8%, surpassing its guidance range, reflecting improved operational efficiency. Additionally, AMN has shown consistent performance with an average surprise in revenue and EBITDA of +3% and +12%, respectively, over the past four quarters, indicating the company's resilience in a challenging market.

Bears say

AMN Healthcare Services Inc reported a decrease in segment revenue for its nurse and allied solutions segment, down 9% year-over-year to $101.8 million, with a gross margin decline of 40 basis points from the previous quarter. Additionally, the company faced a significant 14% year-over-year drop in revenue in its other segment, with an operating margin reduction to 7.5% despite some improvement in gross margin metrics. The overall financial performance was further impacted by a substantial 31% decline in vendor management services (VMS) revenue, highlighting challenges in maintaining growth and profitability across key business areas.

AMN has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 7 analysts, AMN has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.